Issue Date
2021-04-27Keywords
ATPP2X7 receptor
brain diseases
purinergic signaling
shared pathological pathways
Metadata
Show full item recordJournal
Frontiers in molecular neuroscienceDOI
10.3389/fnmol.2021.656011PubMed ID
33986644Item Type
ArticleLanguage
enISSN
1662-5099ae974a485f413a2113503eed53cd6c53
10.3389/fnmol.2021.656011
Scopus Count
Collections
Related articles
- The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
- Authors: Savio LEB, de Andrade Mello P, da Silva CG, Coutinho-Silva R
- Issue date: 2018
- Regulation of P2X7 receptor expression and function in the brain.
- Authors: Jimenez-Mateos EM, Smith J, Nicke A, Engel T
- Issue date: 2019 Sep
- The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases.
- Authors: Chen Z, He L, Li L, Chen L
- Issue date: 2018 Apr
- Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages.
- Authors: Hu Y, Fisette PL, Denlinger LC, Guadarrama AG, Sommer JA, Proctor RA, Bertics PJ
- Issue date: 1998 Oct 16
- P2X7 ionotropic receptor is functionally expressed in rabbit articular chondrocytes and mediates extracellular ATP cytotoxicity.
- Authors: Tanigawa H, Toyoda F, Kumagai K, Okumura N, Maeda T, Matsuura H, Imai S
- Issue date: 2018 Sep